IRIS
BELLOTTI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.530
AS - Asia 6.182
EU - Europa 4.957
SA - Sud America 776
Continente sconosciuto - Info sul continente non disponibili 265
AF - Africa 159
OC - Oceania 15
Totale 20.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.344
CN - Cina 3.082
SG - Singapore 1.336
IE - Irlanda 1.113
HK - Hong Kong 689
UA - Ucraina 616
BR - Brasile 588
FI - Finlandia 557
RU - Federazione Russa 508
DE - Germania 497
IT - Italia 488
VN - Vietnam 459
FR - Francia 336
GB - Regno Unito 291
SE - Svezia 271
IN - India 153
BD - Bangladesh 94
CA - Canada 92
ZA - Sudafrica 68
AR - Argentina 63
PL - Polonia 56
MX - Messico 55
TR - Turchia 48
JP - Giappone 45
BE - Belgio 39
IQ - Iraq 38
ES - Italia 34
NL - Olanda 34
ID - Indonesia 31
CO - Colombia 29
VE - Venezuela 26
PK - Pakistan 25
EC - Ecuador 22
MA - Marocco 22
TN - Tunisia 18
UZ - Uzbekistan 18
PH - Filippine 17
SA - Arabia Saudita 17
KE - Kenya 16
CZ - Repubblica Ceca 15
AT - Austria 12
CL - Cile 12
IL - Israele 12
JO - Giordania 12
BO - Bolivia 11
PE - Perù 11
PY - Paraguay 11
IR - Iran 10
JM - Giamaica 10
KR - Corea 10
LT - Lituania 10
DK - Danimarca 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
EG - Egitto 8
HR - Croazia 8
MY - Malesia 8
GR - Grecia 7
HU - Ungheria 7
KG - Kirghizistan 7
LV - Lettonia 7
MU - Mauritius 7
AZ - Azerbaigian 6
CR - Costa Rica 6
NZ - Nuova Zelanda 6
OM - Oman 6
PT - Portogallo 6
RO - Romania 6
AL - Albania 5
CH - Svizzera 5
HN - Honduras 5
NI - Nicaragua 5
SN - Senegal 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KW - Kuwait 4
LB - Libano 4
MD - Moldavia 4
NP - Nepal 4
RS - Serbia 4
BG - Bulgaria 3
EE - Estonia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
MN - Mongolia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
Totale 20.596
Salva come PNG Salva come JPEG
Città #
Dublin 1.111
Chandler 1.034
San Jose 929
Jacksonville 754
Ashburn 694
Singapore 681
Hong Kong 670
Nanjing 665
Dallas 580
Beijing 541
Boardman 330
Nanchang 277
Council Bluffs 239
Princeton 222
Shenyang 202
Wilmington 200
Hebei 185
Lauterbourg 185
Lawrence 184
Los Angeles 179
Ann Arbor 176
Changsha 174
Helsinki 161
Medford 154
Ho Chi Minh City 146
Jiaxing 135
New York 125
Hanoi 110
Tianjin 106
Munich 104
Milan 103
Buffalo 97
Hangzhou 95
Moscow 89
Shanghai 77
Woodbridge 75
Redondo Beach 71
Santa Clara 67
São Paulo 64
Johannesburg 56
Orem 54
Turku 51
Pavia 46
The Dalles 42
Verona 42
Falls Church 40
Brussels 38
Tokyo 38
Warsaw 38
Chennai 35
Chicago 35
Toronto 32
Denver 31
Frankfurt am Main 31
Brooklyn 30
Norwalk 30
Piscataway 30
Montreal 28
Fairfield 26
London 26
Houston 24
Phoenix 24
Seattle 24
Atlanta 23
Da Nang 23
Stockholm 23
Haiphong 20
Mexico City 20
Rio de Janeiro 20
San Francisco 20
Ankara 19
Guangzhou 19
Jinan 19
Belo Horizonte 18
Falkenstein 18
Rome 18
Boston 17
Washington 17
Amsterdam 16
Baghdad 16
Mumbai 16
Auburn Hills 15
Tashkent 15
Columbus 14
Charlotte 13
Manchester 13
Nuremberg 13
Biên Hòa 12
Bologna 12
Curitiba 12
Istanbul 12
Kunming 12
Nairobi 12
Ningbo 12
Poplar 12
Caracas 11
Lahore 11
Porto Alegre 11
Zhengzhou 11
Buenos Aires 10
Totale 13.417
Salva come PNG Salva come JPEG
Nome #
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 220
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 207
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 202
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 179
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 173
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis 162
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 159
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 154
Biological activity and pathological implications of misfolded proteins. 152
Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. 151
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. 144
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 141
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 141
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy 141
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 140
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 139
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 139
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 138
WALDENSTROM'S HYPERGLOBULINEMIC PURPURA IN HLA IDENTICAL SISTERS. 136
Biochimica Applicata 135
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 135
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 133
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 133
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 131
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 130
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 129
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 129
AMYLOIDOSIS AL 128
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 128
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 128
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 127
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 127
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 127
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 126
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 125
beta 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation 124
Capillary electrophoresis investigation of a partially unfolded conformation of Beta 2-microglobulin. 124
“Separation and quantification of two beta2-microglobulin isoforms”. 122
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 122
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 122
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers. 120
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 120
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 120
Amyloid persistence in decellularized liver: Biochemical and histopathological characterization 120
C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis 120
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 119
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid 119
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 119
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 119
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 117
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 117
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 117
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 116
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 115
Cerebrospinal fluid ferritin in human disease. 115
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 114
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 114
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 113
Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component 113
CHRONIC LYMPHOCYTIC LEUKAEMIA OR IDIOPATHIC COLD HAEMAGGLUTININ DISEASE? A DILEMMA RAISED BY AN ERRONEOUS ELECTRONIC CELL COUNT 111
Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implication 109
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 109
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 108
A Narrative Review of the Role of Transthyretin in Health and Disease 108
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 108
USE OF A MONOCLONAL ANTIBODY AGAINST HUMAN HEART FERRITIN FOR EVALUATING ACIDIC FERRITIN CONCENTRATION IN HUMAN SERUM 107
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 106
Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- And Long-Distance Conformational Changes 106
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. 105
Cinetiche di refolding e studi di affinità mediante elettroforesi capillare: effetto di ligandi di interesse farmaceutico sulla conformazione della Beta 2-microglobulina 105
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. 105
Development of a method to screen potential ligands of amyloidogenic proteins 104
DETECTION OF FRAGMENTS OF BETA2-MICROGLOBULIN IN AMYLOID FIBRILS 104
Conformational transition and cellular toxicity by amyloidogenic proteins 103
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 103
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 103
Proteomics of beta2-microglobulin amyloid fibrils. 102
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 102
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. 102
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils 102
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 101
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin 101
Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity 101
Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability 100
Targeting C-reactive protein for the treatment of cardiovascular disease. 100
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile 100
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine 100
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 99
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 98
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 98
Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity 98
Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro 97
Current concepts on the pathogenisis of systemic amyloidosis 96
Nanobodies against beta2-microglobulin. 96
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes. 96
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 96
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly. 95
PLASMA FERRITIN DETERMINATION AS A DIAGNOSTIC TOOL 95
Solution structure of beta(2)-microglobulin and insights into fibrillogenesis 95
An Asp to Asn mutation is a toxic trigger in beta-2 microglobulin: structure and biophysics 95
Totale 12.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022890 0 7 11 13 28 56 18 64 58 36 132 467
2022/20233.045 365 239 26 219 315 280 0 160 1.307 20 64 50
2023/2024968 136 202 40 57 104 222 12 48 8 41 69 29
2024/20252.973 71 240 78 94 76 111 113 222 779 91 336 762
2025/20267.115 536 499 823 782 842 326 1.394 245 602 573 205 288
2026/2027504 258 246 0 0 0 0 0 0 0 0 0 0
Totale 20.884